{"id":"F2007B01056","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 4 of 2001)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-4-of-2001","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":62536,"registerId":"commonwealth-F2007B01056-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 4 of 2001)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85 (2AA)\n\nNo. PB 4 of 2001\n\nI, BRETT ANTHONY LENNON, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Aged Care and Delegate of the Minister for Health and Aged Care, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:\n\n1.  This Declaration commences on 1 May 2001.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\nEnoxacin\n\nOestradiol and Medroxyprogesterone Acetate\n\nPancreatin\n\nSodium Cellulose Phosphate\n\nDated this 3rd day of April 2001.\n\nBRETT ANTHONY LENNON\n\nAssistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Health and Aged Care\n\nDelegate of the Minister for Health and Aged Care","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1909},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"The declaration performs exactly the function authorised by subsection 85(2AA) of the National Health Act 1953 — removing specific listed drugs from PBS coverage. There is no expansion beyond the original administrative purpose of delisting pharmaceutical benefits."},"complexity_factors":["Very short administrative instrument containing only 2 operative clauses plus a schedule","No defined terms, interpretation section, or legislative cross-references beyond the empowering provision","No conditional logic, exceptions, or procedural requirements","Simple list of 4 specific chemical substances to be removed from subsidy"],"plain_english_summary":"**What this does**\n\nThis declaration removes four specific medicines from Australia's Pharmaceutical Benefits Scheme (PBS) — the government program that subsidises prescription drugs to make them affordable for patients.\n\n**Which medicines are affected**\n\nThe declaration delists:\n- **Enoxacin** (an antibiotic)\n- **Oestradiol and Medroxyprogesterone Acetate** (a hormone replacement therapy)\n- **Pancreatin** (a digestive enzyme supplement)\n- **Sodium Cellulose Phosphate** (used to treat kidney stones)\n\n**What this means for patients**\n\nOnce these drugs are removed from the PBS (effective 1 May 2001), patients must pay the full commercial price rather than the government-subsidised price. The decision was made by a senior health department official acting with the authority of the Health Minister, following advice from the Pharmaceutical Benefits Advisory Committee (the expert body that assesses which medicines should be subsidised)."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-4-of-2001","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-4-of-2001/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-4-of-2001/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-4-of-2001/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-4-of-2001/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-4-of-2001/documents"}}